+15075562445 (US) sales@htfmarketintelligence.com
Point of Care Coagulation Testing Products

Global Point of Care Coagulation Testing Products Market Scope & Changing Dynamics 2025-2033

Global Point of Care Coagulation Testing Products is segmented by Application (Cardiac surgery, Emergency care, Anticoagulant therapy monitoring, Trauma care, Home care), Type (PT/INR meters, ACT monitors, D-dimer POC kits, Thromboelastography, Platelet function POC devices) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)

Pricing
5800
3600
1800

INDUSTRY OVERVIEW

The Point of Care Coagulation Testing Products is Growing at 12.50% and is expected to reach USD4.1Billion by 2033.  Below mentioned are some of the dynamics shaping the Point of Care Coagulation Testing Products.

Point of Care Coagulation Testing Products Market Size in (USD Billion) CAGR Growth Rate 12.50%

Study Period 2020-2033
Market Size (2025): USD1.6Billion
Market Size (2033): USD4.1Billion
CAGR (2025 - 2033): 12.50%
Fastest Growing Region Asia-Pacific
Dominating Region Europe
www.htfmarketinsights.com

These are portable diagnostic devices used to monitor blood coagulation parameters such as PT/INR at the patient’s location. They provide rapid results critical for managing anticoagulant therapies, trauma, or surgical interventions. POC coagulation testing reduces the need for centralized lab analysis, offering convenience and faster clinical decision-making.
Need More Details on Market Players and Competitors?
DOWNLOAD Sample Report

Regulatory Landscape
  • WHO and FDA are emphasizing rapid test approval protocols, boosting adoption.

Market Drivers:
The key drivers in the market include technological advancements, increasing demand by consumers for innovative products, and government-friendly policies. Our research company combines industry reports with expert interviews and market analysis tools to identify and quantify drivers such as these. We review the current trends and gather data from leading industry publications and market research firms to decipher exactly how these and other factors are encouraging or dampening market growth.
  • Growing Prevalence Of Cardiovascular Diseases
  • demand For Near-patient Diagnostics
  • aging Population
  • decentralization Of Healthcare

Market Restraints:
Some of the restraints to market growth may include regulatory challenges, high production costs, and disruptions in the supply chain. Our sources for these limitations include the regulation filings, industry surveys, and direct contributions from active participants within this marketplace. Tracking policy updates and economic reports further helps us to determine what kind of effect these factors have on the industry.
  • Reimbursement Challenges
  • device Calibration Issues
  • regulatory Approvals
  • low Awareness In Rural Areas

Trends in the Market:
Among the trending ones are sustainability, digital transformation, and increasing importance of data analytics. Our research company is tracking these trends through the use of trend analysis tools, social media sentiment analysis, and industry benchmarking studies. Insights in emerging market preferences and technological advancements also come from surveys and focus groups.
  • Handheld coagulation analyzers
  • smartphone-integrated readers
  • AI-assisted results interpretation
  • increased home testing

Market Opportunities:
These include emerging markets, innovation in product development, and strategic partnerships. We identify these opportunities by performing market segmentation analysis, competitive landscape assessment, and investment trend evaluation. The data is collected based on industry reports, financial performance analysis for major players, and forecasting models for identifying future growth areas.
  • Expansion In Rural/remote Care
  • portable Testing For Military/EMS
  • growth In Chronic Disease Management
  • pharma Partnerships

Check Out Prices
Get Price

Regulation Shaping the Healthcare Industry

The healthcare industry is significantly influenced by a complex framework of regulations designed to ensure patient safety, efficacy of treatments, and the overall quality of care. Key regulatory areas include drug approval processes, medical device standards, and healthcare data protection. These regulations aim to maintain high standards for clinical practices and safeguard public health.

Major Regulatory Bodies Worldwide

1. U.S. Food and Drug Administration (FDA): In the United States, the FDA is a pivotal regulatory authority overseeing the approval and monitoring of pharmaceuticals, medical devices, and biologics. The FDA sets stringent standards for product safety and efficacy, which significantly impacts market entry and ongoing compliance for healthcare companies.
2. European Medicines Agency (EMA): The EMA plays a crucial role in the European Union, evaluating and supervising medicinal products. It provides centralized approval for drugs and ensures that products meet rigorous safety and efficacy standards across member states.
3. Health Canada: This agency regulates pharmaceuticals and medical devices in Canada, ensuring that products are safe, effective, and of high quality. Health Canada's regulations are aligned with international standards but tailored to meet national health needs.
4. World Health Organization (WHO): While not a regulatory body in the traditional sense, the WHO sets international health standards and provides guidelines that influence national regulatory frameworks. It plays a key role in global health policy and emergency response.
5. National Medical Products Administration (NMPA): In China, the NMPA regulates the approval and supervision of drugs and medical devices, with an increasing focus on aligning with global standards and facilitating market access.
Request for Customization
Get Customization

SWOT Analysis in the Healthcare Industry

SWOT analysis in the healthcare industry involves a structured assessment of Strengths, Weaknesses, Opportunities, and Threats to identify strategic advantages and areas for improvement.
•    Strengths: Evaluates internal factors such as advanced technology, skilled personnel, and strong brand reputation. For example, a hospital with cutting-edge medical equipment and specialized staff is considered to have a strong competitive edge.
•    Weaknesses: Identifies internal limitations like outdated facilities, regulatory compliance issues, or high operational costs. Weaknesses could include inefficient processes or lack of innovation.
•    Opportunities: Assesses external factors that could drive growth, such as emerging medical technologies, expanding markets, or favorable government policies. Opportunities might involve partnerships or new service lines.
•    Threats: Examines external challenges such as increasing competition, changing regulations, or economic downturns. Threats might include new entrants with disruptive technologies or stricter regulatory requirements.

Market Segmentation

Segmentation by Type

  • PT/INR meters
  • ACT monitors
  • D-dimer POC kits
  • Thromboelastography

Point of Care Coagulation Testing Products Market Segmentation by Type

www.htfmarketinsights.com

Segmentation by Application

  • Cardiac surgery
  • Emergency care
  • Anticoagulant therapy monitoring
  • Trauma care
  • Home care

Point of Care Coagulation Testing Products Market Segmentation by Application

www.htfmarketinsights.com

Regional Outlook

The Europe currently holds a significant share of the market, primarily due to several key factors: increasing consumption rates, a burgeoning population, and robust economic momentum. These elements collectively drive demand, positioning this region as a leader in the market. On the other hand, Asia-Pacific is rapidly emerging as the fastest-growing area within the industry. This remarkable growth can be attributed to swift infrastructure development, the expansion of various industrial sectors, and a marked increase in consumer demand. These dynamics make this region a crucial player in shaping future market growth. In our report, we cover a comprehensive analysis of the regions and countries, including 
Regions
  • North America
  • LATAM
  • West Europe
  • Central & Eastern Europe
  • Northern Europe
  • Southern Europe
  • East Asia
  • Southeast Asia
  • South Asia
  • Central Asia
  • Oceania
  • MEA
Fastest Growing Region
Asia-Pacific
Asia-Pacific dominates Point of Care Coagulation Testing Products Market [2020 to 2025]
Dominating Region
Europe
Europe dominates Point of Care Coagulation Testing Products Market [2020 to 2025]


The company consistently allocates significant resources to expand its research capabilities, develop new medical technologies, and enhance its pharmaceutical portfolio. Johnson & Johnson's investments in R&D, coupled with strategic acquisitions and partnerships, reinforce its position as a major contributor to advancements in healthcare. This focus on innovation and market expansion underscores the critical importance of the North American region in the global healthcare landscape.
  • Roche Diagnostics (Switzerland)
  • Siemens Healthineers (Germany)
  • Abbott (USA)
  • Werfen (Spain)
  • HemoSonics (USA)
  • Medtronic (Ireland)
  • iLine Microsystems (Spain)
  • Helena Laboratories (USA)
  • Haemonetics (USA)
  • Micropoint Bioscience (China)
  • Roche Cobas (Switzerland)
  • Stago (France)
  • Sysmex Corporation (Japan)
  • Medix Biochemica (Finland)

Point of Care Coagulation Testing Products Market Segmentation by Players

www.htfmarketinsights.com

 

Regional Analysis

  • Dominant in North America and Western Europe, with rising uptake in Brazil and UAE.

Market Entropy

  • July 2025: Roche Diagnostics introduced a rapid POC coagulation testing system for critical care settings, enabling faster anticoagulant monitoring.

Merger & Acquisition

  • May 2025 – Roche acquired a U.S.-based POC diagnostics firm. Following the merger, it introduced "CoaguSmart X" – a wireless INR testing device for rapid home and clinic use.

Regulatory Landscape

  • WHO and FDA are emphasizing rapid test approval protocols, boosting adoption.

Patent Analysis

  • Patents in multi-marker detection, lab-on-chip sensors, and automated clot timing tech.

Investment and Funding Scenario

  • Funding high in telemedicine and emergency home diagnostics sectors.

Primary and Secondary Research

Primary research involves the collection of original data directly from sources in the healthcare industry. Approaches include the survey of health professionals, interviews with patients, focus groups, and clinical trials. This gives an overview of the current practice, the needs of the patient, and the interest in emerging trends. Firsthand information on the efficacy of new treatments, an assessment of market demand, and insight into changes in regulation can be sought only with primary research.
Secondary Research: This is the investigation of existing information from a variety of sources, which may include industry reports, academic journals, government publications, and market research studies. Alfred secondary research empowers them to understand trends within industries, historical data, and competitive landscapes. It gives a wide view of the market dynamics and validates findings obtained from primary research. By combining both primary and secondary together, health organizations will be empowered to develop comprehensive strategies and make informed decisions based on a strong foundation built on data.

Report Infographics

Report Features

Details

Base Year

2025

Based Year Market Size (2023)

USD1.6Billion

Historical Period

2020 to 2025

CAGR (2025 to 2033)

12.50%

Forecast Period

2025 to 2033

Forecasted Period Market Size (2033)

USD4.1Billion

Scope of the Report

Segmentation by Type
PT/INR meters,ACT monitors,D-dimer POC kits,Thromboelastography,
Segmentation by Application
Cardiac surgery,Emergency care,Anticoagulant therapy monitoring,Trauma care,Home care, Sales Channel

Regions Covered

North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA

Companies Covered

Roche Diagnostics (Switzerland),Siemens Healthineers (Germany),Abbott (USA),Werfen (Spain),HemoSonics (USA),Medtronic (Ireland),iLine Microsystems (Spain),Helena Laboratories (USA),Haemonetics (USA),Micropoint Bioscience (China),Roche Cobas (Switzerland),Stago (France),Sysmex Corporation (Japan),Medix Biochemica (Finland)

Customization Scope

15% Free Customization (For EG)

Delivery Format

PDF and Excel through Email

Point of Care Coagulation Testing Products - Table of Contents

Chapter 1: Market Preface
  • 1.1 Global Point of Care Coagulation Testing Products Market Landscape
  • 1.2 Scope of the Study
  • 1.3 Relevant Findings & Stakeholder Advantages

Chapter 2: Strategic Overview
  • 2.1 Global Point of Care Coagulation Testing Products Market Outlook
  • 2.2 Total Addressable Market versus Serviceable Market
  • 2.3 Market Rivalry Projection

Chapter 3 : Global Point of Care Coagulation Testing Products Market Business Environment & Changing Dynamics
  • 3.1 Growth Drivers
    • 3.1.1 Growing prevalence of cardiovascular diseases
    • 3.1.2 demand for near-patient diagnostics
    • 3.1.3 aging population
    • 3.1.4 decentralization of healthcare
  • 3.2 Available Opportunities
    • 3.2.1 Expansion in rural/remote care
    • 3.2.2 portable testing for military/EMS
    • 3.2.3 growth in chronic disease managem
  • 3.3 Influencing Trends
    • 3.3.1 Handheld coagulation analyzers
    • 3.3.2 smartphone-integrated readers
    • 3.3.3 AI-assisted results interpretation
    • 3.3.4 in
  • 3.4 Challenges
    • 3.4.1 Reimbursement challenges
    • 3.4.2 device calibration issues
    • 3.4.3 regulatory approvals
    • 3.4.4 low awareness in rural are
  • 3.5 Regional Dynamics

Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global Point of Care Coagulation Testing Products Industry Factors Assessment
  • 4.1 Current Scenario
  • 4.2 PEST Analysis
  • 4.3 Business Environment - PORTER 5-Forces Analysis
    • 4.3.1 Supplier Leverage
    • 4.3.2 Bargaining Power of Buyers
    • 4.3.3 Threat of Substitutes
    • 4.3.4 Threat from New Entrant
    • 4.3.5 Market Competition Level
  • 4.4 Roadmap of Point of Care Coagulation Testing Products Market
  • 4.5 Impact of Macro-Economic Factors
  • 4.6 Market Entry Strategies
  • 4.7 Political and Regulatory Landscape
  • 4.8 Supply Chain Analysis
  • 4.9 Impact of Tariff War


Chapter 5: Point of Care Coagulation Testing Products : Competition Benchmarking & Performance Evaluation
  • 5.1 Global Point of Care Coagulation Testing Products Market Concentration Ratio
    • 5.1.1 CR4, CR8 and HH Index
    • 5.1.2 % Market Share - Top 3
    • 5.1.3 Market Holding by Top 5
  • 5.2 Market Position of Manufacturers by Point of Care Coagulation Testing Products Revenue 2025
  • 5.3 Global Point of Care Coagulation Testing Products Sales Volume by Manufacturers (2025)
  • 5.4 BCG Matrix
  • 5.4 Market Entropy
  • 5.5 Heat Map Analysis
  • 5.6 Strategic Group Analysis
Chapter 6: Global Point of Care Coagulation Testing Products Market: Company Profiles
  • 6.1 Roche Diagnostics (Switzerland)
    • 6.1.1 Roche Diagnostics (Switzerland) Company Overview
    • 6.1.2 Roche Diagnostics (Switzerland) Product/Service Portfolio & Specifications
    • 6.1.3 Roche Diagnostics (Switzerland) Key Financial Metrics
    • 6.1.4 Roche Diagnostics (Switzerland) SWOT Analysis
    • 6.1.5 Roche Diagnostics (Switzerland) Development Activities
  • 6.2 Siemens Healthineers (Germany)
  • 6.3 Abbott (USA)
  • 6.4 Werfen (Spain)
  • 6.5 HemoSonics (USA)
  • 6.6 Medtronic (Ireland)
  • 6.7 ILine Microsystems (Spain)
  • 6.8 Helena Laboratories (USA)
  • 6.9 Haemonetics (USA)
  • 6.10 Micropoint Bioscience (China)
  • 6.11 Roche Cobas (Switzerland)
  • 6.12 Stago (France)
  • 6.13 Sysmex Corporation (Japan)
  • 6.14 Medix Biochemica (Finland)
  • 6.15 CoaguSense (USA)

To View a Complete List of Players? Inquiry Now
Sectional Purchase

Chapter 7 : Global Point of Care Coagulation Testing Products by Type & Application (2020-2033)
  • 7.1 Global Point of Care Coagulation Testing Products Market Revenue Analysis (USD Million) by Type (2020-2025)
    • 7.1.1 PT/INR Meters
    • 7.1.2 ACT Monitors
    • 7.1.3 D-dimer POC Kits
    • 7.1.4 Thromboelastography
    • 7.1.5 Platelet Function POC Devices
  • 7.2 Global Point of Care Coagulation Testing Products Market Revenue Analysis (USD Million) by Application (2020-2025)
    • 7.2.1 Cardiac Surgery
    • 7.2.2 Emergency Care
    • 7.2.3 Anticoagulant Therapy Monitoring
    • 7.2.4 Trauma Care
    • 7.2.5 Home Care
  • 7.3 Global Point of Care Coagulation Testing Products Market Revenue Analysis (USD Million) by Type (2025-2033)
  • 7.4 Global Point of Care Coagulation Testing Products Market Revenue Analysis (USD Million) by Application (2025-2033)

Chapter 8 : North America Point of Care Coagulation Testing Products Market Breakdown by Country, Type & Application
  • 8.1 North America Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
    • 8.1.1 United States
    • 8.1.2 Canada
  • 8.2 North America Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
    • 8.2.1 PT/INR Meters
    • 8.2.2 ACT Monitors
    • 8.2.3 D-dimer POC Kits
    • 8.2.4 Thromboelastography
    • 8.2.5 Platelet Function POC Devices
  • 8.3 North America Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
    • 8.3.1 Cardiac Surgery
    • 8.3.2 Emergency Care
    • 8.3.3 Anticoagulant Therapy Monitoring
    • 8.3.4 Trauma Care
    • 8.3.5 Home Care
  • 8.4 North America Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
  • 8.5 North America Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
  • 8.6 North America Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Looking for Section Purchase? Get Quote Now
Sectional Purchase

Chapter 9 : LATAM Point of Care Coagulation Testing Products Market Breakdown by Country, Type & Application
  • 9.1 LATAM Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
    • 9.1.1 Brazil
    • 9.1.2 Argentina
    • 9.1.3 Chile
    • 9.1.4 Mexico
    • 9.1.5 Rest of LATAM
  • 9.2 LATAM Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
    • 9.2.1 PT/INR Meters
    • 9.2.2 ACT Monitors
    • 9.2.3 D-dimer POC Kits
    • 9.2.4 Thromboelastography
    • 9.2.5 Platelet Function POC Devices
  • 9.3 LATAM Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
    • 9.3.1 Cardiac Surgery
    • 9.3.2 Emergency Care
    • 9.3.3 Anticoagulant Therapy Monitoring
    • 9.3.4 Trauma Care
    • 9.3.5 Home Care
  • 9.4 LATAM Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
  • 9.5 LATAM Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
  • 9.6 LATAM Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 10 : West Europe Point of Care Coagulation Testing Products Market Breakdown by Country, Type & Application
  • 10.1 West Europe Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
    • 10.1.1 Germany
    • 10.1.2 France
    • 10.1.3 Benelux
    • 10.1.4 Switzerland
    • 10.1.5 Rest of West Europe
  • 10.2 West Europe Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
    • 10.2.1 PT/INR Meters
    • 10.2.2 ACT Monitors
    • 10.2.3 D-dimer POC Kits
    • 10.2.4 Thromboelastography
    • 10.2.5 Platelet Function POC Devices
  • 10.3 West Europe Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
    • 10.3.1 Cardiac Surgery
    • 10.3.2 Emergency Care
    • 10.3.3 Anticoagulant Therapy Monitoring
    • 10.3.4 Trauma Care
    • 10.3.5 Home Care
  • 10.4 West Europe Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
  • 10.5 West Europe Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
  • 10.6 West Europe Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 11 : Central & Eastern Europe Point of Care Coagulation Testing Products Market Breakdown by Country, Type & Application
  • 11.1 Central & Eastern Europe Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
    • 11.1.1 Bulgaria
    • 11.1.2 Poland
    • 11.1.3 Hungary
    • 11.1.4 Romania
    • 11.1.5 Rest of CEE
  • 11.2 Central & Eastern Europe Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
    • 11.2.1 PT/INR Meters
    • 11.2.2 ACT Monitors
    • 11.2.3 D-dimer POC Kits
    • 11.2.4 Thromboelastography
    • 11.2.5 Platelet Function POC Devices
  • 11.3 Central & Eastern Europe Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
    • 11.3.1 Cardiac Surgery
    • 11.3.2 Emergency Care
    • 11.3.3 Anticoagulant Therapy Monitoring
    • 11.3.4 Trauma Care
    • 11.3.5 Home Care
  • 11.4 Central & Eastern Europe Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
  • 11.5 Central & Eastern Europe Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
  • 11.6 Central & Eastern Europe Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 12 : Northern Europe Point of Care Coagulation Testing Products Market Breakdown by Country, Type & Application
  • 12.1 Northern Europe Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
    • 12.1.1 The United Kingdom
    • 12.1.2 Sweden
    • 12.1.3 Norway
    • 12.1.4 Baltics
    • 12.1.5 Ireland
    • 12.1.6 Rest of Northern Europe
  • 12.2 Northern Europe Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
    • 12.2.1 PT/INR Meters
    • 12.2.2 ACT Monitors
    • 12.2.3 D-dimer POC Kits
    • 12.2.4 Thromboelastography
    • 12.2.5 Platelet Function POC Devices
  • 12.3 Northern Europe Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
    • 12.3.1 Cardiac Surgery
    • 12.3.2 Emergency Care
    • 12.3.3 Anticoagulant Therapy Monitoring
    • 12.3.4 Trauma Care
    • 12.3.5 Home Care
  • 12.4 Northern Europe Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
  • 12.5 Northern Europe Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
  • 12.6 Northern Europe Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 13 : Southern Europe Point of Care Coagulation Testing Products Market Breakdown by Country, Type & Application
  • 13.1 Southern Europe Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
    • 13.1.1 Spain
    • 13.1.2 Italy
    • 13.1.3 Portugal
    • 13.1.4 Greece
    • 13.1.5 Rest of Southern Europe
  • 13.2 Southern Europe Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
    • 13.2.1 PT/INR Meters
    • 13.2.2 ACT Monitors
    • 13.2.3 D-dimer POC Kits
    • 13.2.4 Thromboelastography
    • 13.2.5 Platelet Function POC Devices
  • 13.3 Southern Europe Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
    • 13.3.1 Cardiac Surgery
    • 13.3.2 Emergency Care
    • 13.3.3 Anticoagulant Therapy Monitoring
    • 13.3.4 Trauma Care
    • 13.3.5 Home Care
  • 13.4 Southern Europe Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
  • 13.5 Southern Europe Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
  • 13.6 Southern Europe Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 14 : East Asia Point of Care Coagulation Testing Products Market Breakdown by Country, Type & Application
  • 14.1 East Asia Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
    • 14.1.1 China
    • 14.1.2 Japan
    • 14.1.3 South Korea
    • 14.1.4 Taiwan
    • 14.1.5 Others
  • 14.2 East Asia Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
    • 14.2.1 PT/INR Meters
    • 14.2.2 ACT Monitors
    • 14.2.3 D-dimer POC Kits
    • 14.2.4 Thromboelastography
    • 14.2.5 Platelet Function POC Devices
  • 14.3 East Asia Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
    • 14.3.1 Cardiac Surgery
    • 14.3.2 Emergency Care
    • 14.3.3 Anticoagulant Therapy Monitoring
    • 14.3.4 Trauma Care
    • 14.3.5 Home Care
  • 14.4 East Asia Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
  • 14.5 East Asia Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
  • 14.6 East Asia Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 15 : Southeast Asia Point of Care Coagulation Testing Products Market Breakdown by Country, Type & Application
  • 15.1 Southeast Asia Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
    • 15.1.1 Vietnam
    • 15.1.2 Singapore
    • 15.1.3 Thailand
    • 15.1.4 Malaysia
    • 15.1.5 Indonesia
    • 15.1.6 Philippines
    • 15.1.7 Rest of SEA Countries
  • 15.2 Southeast Asia Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
    • 15.2.1 PT/INR Meters
    • 15.2.2 ACT Monitors
    • 15.2.3 D-dimer POC Kits
    • 15.2.4 Thromboelastography
    • 15.2.5 Platelet Function POC Devices
  • 15.3 Southeast Asia Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
    • 15.3.1 Cardiac Surgery
    • 15.3.2 Emergency Care
    • 15.3.3 Anticoagulant Therapy Monitoring
    • 15.3.4 Trauma Care
    • 15.3.5 Home Care
  • 15.4 Southeast Asia Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
  • 15.5 Southeast Asia Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
  • 15.6 Southeast Asia Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 16 : South Asia Point of Care Coagulation Testing Products Market Breakdown by Country, Type & Application
  • 16.1 South Asia Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
    • 16.1.1 India
    • 16.1.2 Bangladesh
    • 16.1.3 Others
  • 16.2 South Asia Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
    • 16.2.1 PT/INR Meters
    • 16.2.2 ACT Monitors
    • 16.2.3 D-dimer POC Kits
    • 16.2.4 Thromboelastography
    • 16.2.5 Platelet Function POC Devices
  • 16.3 South Asia Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
    • 16.3.1 Cardiac Surgery
    • 16.3.2 Emergency Care
    • 16.3.3 Anticoagulant Therapy Monitoring
    • 16.3.4 Trauma Care
    • 16.3.5 Home Care
  • 16.4 South Asia Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
  • 16.5 South Asia Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
  • 16.6 South Asia Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 17 : Central Asia Point of Care Coagulation Testing Products Market Breakdown by Country, Type & Application
  • 17.1 Central Asia Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
    • 17.1.1 Kazakhstan
    • 17.1.2 Tajikistan
    • 17.1.3 Others
  • 17.2 Central Asia Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
    • 17.2.1 PT/INR Meters
    • 17.2.2 ACT Monitors
    • 17.2.3 D-dimer POC Kits
    • 17.2.4 Thromboelastography
    • 17.2.5 Platelet Function POC Devices
  • 17.3 Central Asia Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
    • 17.3.1 Cardiac Surgery
    • 17.3.2 Emergency Care
    • 17.3.3 Anticoagulant Therapy Monitoring
    • 17.3.4 Trauma Care
    • 17.3.5 Home Care
  • 17.4 Central Asia Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
  • 17.5 Central Asia Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
  • 17.6 Central Asia Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 18 : Oceania Point of Care Coagulation Testing Products Market Breakdown by Country, Type & Application
  • 18.1 Oceania Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
    • 18.1.1 Australia
    • 18.1.2 New Zealand
    • 18.1.3 Others
  • 18.2 Oceania Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
    • 18.2.1 PT/INR Meters
    • 18.2.2 ACT Monitors
    • 18.2.3 D-dimer POC Kits
    • 18.2.4 Thromboelastography
    • 18.2.5 Platelet Function POC Devices
  • 18.3 Oceania Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
    • 18.3.1 Cardiac Surgery
    • 18.3.2 Emergency Care
    • 18.3.3 Anticoagulant Therapy Monitoring
    • 18.3.4 Trauma Care
    • 18.3.5 Home Care
  • 18.4 Oceania Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
  • 18.5 Oceania Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
  • 18.6 Oceania Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 19 : MEA Point of Care Coagulation Testing Products Market Breakdown by Country, Type & Application
  • 19.1 MEA Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
    • 19.1.1 Turkey
    • 19.1.2 South Africa
    • 19.1.3 Egypt
    • 19.1.4 UAE
    • 19.1.5 Saudi Arabia
    • 19.1.6 Israel
    • 19.1.7 Rest of MEA
  • 19.2 MEA Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
    • 19.2.1 PT/INR Meters
    • 19.2.2 ACT Monitors
    • 19.2.3 D-dimer POC Kits
    • 19.2.4 Thromboelastography
    • 19.2.5 Platelet Function POC Devices
  • 19.3 MEA Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
    • 19.3.1 Cardiac Surgery
    • 19.3.2 Emergency Care
    • 19.3.3 Anticoagulant Therapy Monitoring
    • 19.3.4 Trauma Care
    • 19.3.5 Home Care
  • 19.4 MEA Point of Care Coagulation Testing Products Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
  • 19.5 MEA Point of Care Coagulation Testing Products Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
  • 19.6 MEA Point of Care Coagulation Testing Products Market by Application (USD Million) & Sales Volume (Units) [2026-2033]

Chapter 20: Research Findings & Conclusion
  • 20.1 Key Findings
  • 20.2 Conclusion

Chapter 21: Methodology and Data Source
  • 21.1 Research Methodology & Approach
    • 21.1.1 Research Program/Design
    • 21.1.2 Market Size Estimation
    • 21.1.3 Market Breakdown and Data Triangulation
  • 21.2 Data Source
    • 21.2.1 Secondary Sources
    • 21.2.2 Primary Sources

Chapter 22: Appendix & Disclaimer
  • 22.1 Acronyms & bibliography
  • 22.2 Disclaimer

Frequently Asked Questions (FAQ):

The Global Point of Care Coagulation Testing Products market size surpassed USD 1.6 Billion in 2025 and will expand at a CAGR of 12.50% between 2025 and 2033.

According to the report,the Point of Care Coagulation Testing Products Industry size is projected to reach USD 4.1 Billion, exhibiting a CAGR of 12.50% by 2033.

The changing dynamics and trends such as Handheld Coagulation Analyzers,smartphone-integrated Readers,AI-assisted Results Interpretation,increased Home Testing,integration With Telehealth are seen as major Game Changer in Global Point of Care Coagulation Testing Products Market.

The leaders in the Global Point of Care Coagulation Testing Products Market such as Roche Diagnostics (Switzerland),Siemens Healthineers (Germany),Abbott (USA),Werfen (Spain),HemoSonics (USA),Medtronic (Ireland),iLine Microsystems (Spain),Helena Laboratories (USA),Haemonetics (USA),Micropoint Bioscience (China),Roche Cobas (Switzerland),Stago (France),Sysmex Corporation (Japan),Medix Biochemica (Finland),CoaguSense (USA) are targeting innovative and differentiated growth drivers some of them are Growing Prevalence Of Cardiovascular Diseases,demand For Near-patient Diagnostics,aging Population,decentralization Of Healthcare,rapid Surgery Triage

Some of the major challanges seen in Global Point of Care Coagulation Testing Products Market are Reimbursement Challenges,device Calibration Issues,regulatory Approvals,low Awareness In Rural Areas,competition From Lab-based Tests.

Some of the opportunities that Analyst at HTF MI have identified in Point of Care Coagulation Testing Products Market are:
  • Expansion In Rural/remote Care
  • portable Testing For Military/EMS
  • growth In Chronic Disease Management
  • pharma Partnerships
  • technology Miniaturization

Roche Diagnostics (Switzerland),Siemens Healthineers (Germany),Abbott (USA),Werfen (Spain),HemoSonics (USA),Medtronic (Ireland),iLine Microsystems (Spain),Helena Laboratories (USA),Haemonetics (USA),Micropoint Bioscience (China),Roche Cobas (Switzerland),Stago (France),Sysmex Corporation (Japan),Medix Biochemica (Finland),CoaguSense (USA) are the major operating companies profiled in Point of Care Coagulation Testing Products market study.

Research paper of Global Point of Care Coagulation Testing Products Market shows that companies are making better progress than their supply chain peers –including suppliers, majorly in end-use applications such as Cardiac surgery,Emergency care,Anticoagulant therapy monitoring,Trauma care,Home care.

The Global Point of Care Coagulation Testing Products Market Study is segmented by PT/INR meters,ACT monitors,D-dimer POC kits,Thromboelastography,Platelet function POC devices.

The Global Point of Care Coagulation Testing Products Market Study includes regional breakdown as North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA

The Point of Care Coagulation Testing Products Market is studied from 2020 - 2033.

These are portable diagnostic devices used to monitor blood coagulation parameters such as PT/INR at the patient’s location. They provide rapid results critical for managing anticoagulant therapies, trauma, or surgical interventions. POC coagulation testing reduces the need for centralized lab analysis, offering convenience and faster clinical decision-making.
HTF MI Logo

Contact Info

304 B, Town Square, New Airport Road, Viman Nagar, Pune - 411014 sales@htfmarketintelligence.com +15075562445 (US)

Explore

Home About Us Reports Category Contact Us FAQs

Policy

Terms & Conditions Privacy Policy
HTF Market Intelligence, All right reserved 2025.
Designed By S3World